![Garratt W. Ponder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Garratt W. Ponder
Corporate Officer/Principal chez
Tikvah Therapeutics, Inc.
Profil
Garratt W.
Ponder is Vice President of Pharmaceutical Development for Tikvah Therapeutics, Inc. Prior to joining Tikvah Therapeutics, he was Senior Director of Product Development for AtheroGenics, Inc. Before joining AtheroGenics in 2003, he worked at Endeavor Pharmaceuticals, Inc. and Solvay Pharmaceuticals, Inc. He has over 12 years of experience in analytical chemistry, process chemistry, and pharmaceutical development.
Dr. Ponder received a BS degree in Chemistry in 1989 and a PhD in Pharmaceutical Analysis from the University of Georgia in 1995.
Postes actifs de Garratt W. Ponder
| Sociétés | Poste | Début |
|---|---|---|
Tikvah Therapeutics, Inc.
 Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutic products | Corporate Officer/Principal | - |
Anciens postes connus de Garratt W. Ponder
| Sociétés | Poste | Fin |
|---|---|---|
Endeavor Pharmaceuticals, Inc.
 Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures hormone replacement pharmaceutical products | Corporate Officer/Principal | - |
Solvay Pharmaceuticals, Inc.
 Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Corporate Officer/Principal | - |
Formation de Garratt W. Ponder
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Endeavor Pharmaceuticals, Inc.
Endeavor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures hormone replacement pharmaceutical products | Health Technology |
Tikvah Therapeutics, Inc.
Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutic products | Health Technology |
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Georgia
 University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
